Conexeu Sciences Inc. News Releases

Conexeu Sciences Appoints Jean-Romain (JR) Falconnet as Head of Business Development & Licensing

Mon, 02 Mar 2026 09:03:00 -0500

Reno, Nevada--(Newsfile Corp. - March 2, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation extracellular matrix platform, is pleased to announce Jean-Romain (JR) Falconnet as Head of Business Development & Licensing.In his role at Conexeu, JR will lead business development, licensing strategy, and strategic partnerships—supporting the company's growth roadmap and expanding opportunities to bring...

Conexeu Sciences Appoints Sonia Thomas as Head of Strategy & Transformation to Accelerate Enterprise Growth and Execution Excellence

Mon, 09 Feb 2026 09:00:00 -0500

Reno, Nevada--(Newsfile Corp. - February 9, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company") a biotechnology innovator redefining regenerative medicine through a next-generation extracellular matrix platform, is pleased to announce Sonia Thomas, MBA, as Head of Strategy & Transformation.In her role, Sonia will help define Conexeu's enterprise strategy, shape portfolio priorities, and long-term growth decisions, and lead cross-functional transformation initiatives that strengthen...

Conexeu Sciences Signals a Major Breakthrough in 'Personalized Human Tissue Creation'

Thu, 20 Nov 2025 09:00:00 -0500

Reno, Nevada--(Newsfile Corp. - November 20, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation collagen-based platform, is pleased to announce that it has achieved a defining milestone in regenerative medicine with the first ever 3D-printed structures made entirely from its patented, functional extracellular matrix (ECM). Using its patented CXU™ platform, the Company has printed bovine-derived...

Conexeu Sciences Inc. Expands Board of Directors with the Appointments of Dr. Aaron Farberg and Dr. Sebastian Purcell

Wed, 05 Nov 2025 07:00:00 -0500

Reno, Nevada--(Newsfile Corp. - November 5, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation collagen-based platform, today announced the appointments of Aaron Farberg, M.D. and Sebastian Purcell, Ph.D. to its Board of Directors. The additions bring together leading expertise from the worlds of medicine, science, and ethics-driven innovation as Conexeu advances its mission to pioneer collagen-based...

Conexeu Sciences Appoints Miles Harrison as President & Chief Executive Officer, to Shape the Future of True Tissue Regeneration

Mon, 03 Nov 2025 07:00:00 -0500

Reno, Nevada--(Newsfile Corp. - November 3, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a pre-commercial biotechnology company redefining regenerative medicine through next-generation collagen science, announces the appointment of Miles D. Harrison as President & Chief Executive Officer of the Company. He has also been appointed to the Company's Board of Directors.At Conexeu, Miles will lead the Company's next phase of growth, advancing its first-in-class collagen platform for...

Conexeu Sciences Closes Maximum $5M Reg CF Financing

Thu, 16 Oct 2025 09:01:00 -0400

Reno, Nevada--(Newsfile Corp. - October 16, 2025) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a biotechnology company revolutionizing tissue regeneration, is pleased to announce the completion of its $5 million Regulation Crowdfunding (Reg CF) financing. Conexeu secured commitments in excess of $5 million in less than two weeks from the date of launching the financing through the Equifund platform. Conexeu Chief Executive Officer, Jeff Sharpe, stated, "This milestone highlights the...